Vyne Therapeutics has given up hopes of resuming a plaque psoriasis trial for its BET inhibitor placed on hold by the FDA, ...

AbbVie is on board with the idea. The Big Pharma will pay up to $2.1 billion in cash at closing to acquire Capstan. In return ...

In the July 2 release, 4DMT explained that the 25% layoffs are part of a move to “streamline operations to offset additional ...

Catalio Capital Management has closed its fourth venture fund with more than $400 million that will be used in part to launch ...

After claiming an FDA approval last year, Intuitive has obtained a greenlight in Europe for its latest surgical robot, the da ...

On Wednesday, Biokin reported (PDF) positive topline results from a phase 3 trial of the ADC. The study enrolled patients ...

Amgen’s investigational monoclonal antibody paired with chemotherapy significantly improved overall survival for patients in ...

Storied Japanese pharma Shionogi is upping its arsenal in the fight against antibiotic resistance. | Storied Japanese pharma ...

Inhibiting an overabundant enzyme saved a key component of a brain signaling pathway that is vital for motor control in a ...

A group of 53 biotech leaders are expressing their support for mifepristone in a letter to the Food and Drug Administration, urging the agency not to impose new restrictions on its use as an abortion ...

The pulsed field ablation developer Kardium has collected $250 million in funding to gear up for the commercial expansion of ...

Sanofi has doubled down on its partnership with Adagene, investing $25 million in the biotech, taking up its option on a ...